Navigation Links
US Department of Defense helps move spinal cord injury treatment closer to clinical trials
Date:6/21/2010

The United States Department of Defense Spinal Cord Injury Research Program has announced a grant of more than a million dollars U.S. to support research at the Robarts Research Institute at The University of Western Ontario (Western). The spinal cord injury research team of Gregory Dekaban, Arthur Brown, Lynne Weaver and Paula Foster, in collaboration with Brian Kwon of the University of British Columbia and Kyle Petersen of the U.S. Naval Medical Research Center, is working on a new therapy designed to limit the damage caused by inflammation immediately following spinal cord injury. The grant will move their work, led by Dekaban, closer to a clinical trial.

Nearly a quarter of wounded military personnel requiring evacuation from the field suffer spinal cord or traumatic brain injury. As well, 12,000 new cases of spinal cord injury occur every year in the North American civilian population. Spinal cord injury creates physical, psychological and financial challenges to the injured and their families. These injuries are also a significant burden for health care systems.

Spinal cord injury occurs in two stages. The first is the physical injury from trauma; the second stage, that extends the initial damage, is caused in large part by inflammation in the spinal cord. "This antibody therapy is designed to be given by intravenous injection as soon as possible after a person comes into the emergency department with a spinal cord injury, or at least within 24 hours," explains Dekaban, a Robarts Scientist in the Molecular Brain Research Group and Professor in the Department of Microbiology and Immunology at Western's Schulich School of Medicine & Dentistry. "In our preclinical models, it's been shown to make a significant improvement in recovery. This antibody treatment could also be effective for traumatic brain injury. "

The antibody targets a protein known as CD11d on the surface of inflammatory cells that circulate in blood. CD11d is required by white blood cells to leave the bloodstream and enter the injured spinal cord. The anti-CD11d antibody is designed to block that process. By blocking the entry and retention of these white blood cells at the site of injury, the researchers successfully reduced inflammation and improved neurological recovery in preclinical models of spinal cord injury.

The research at Robarts so far has employed a mouse antibody that recognizes human CD11d. This new award from the Spinal Cord Injury Research Program funded by the Department of Defense Congressionally Directed Medical Research Program will support the development of a humanized antibody suitable for use in a clinical trial. This research will be carried out in conjunction with Eli Lilly and Company.

The spinal cord injury team at Robarts has been working on this project for a decade. "This project highlights the importance of peer-reviewed funding in producing new discoveries in neuroscience and the subsequent role of university-industry partnerships in commercializing such technologies," says Ravi Menon, Deputy Director of Robarts. "Robarts continues to excel at all aspects of the discovery cycle, with the rigorously evaluated results benefitting patients and creating commercial value."


'/>"/>

Contact: Kathy Wallis
kwallis3@uwo.ca
519-661-2111 x81136
University of Western Ontario
Source:Eurekalert

Related medicine news :

1. Department of Labor Raises the Bar
2. Hospital Physician Partners and Lock Haven Hospital Announce New Emergency Department Partnership
3. US Department of Education Financial Aid Approval
4. 2 studies: Social factors, super users and urban emergency departments
5. Florida Department of Health Launches Redesigned Website for HIV Campaign
6. Zvetco Biometrics Delivers Needed Authentication for New York City Department of Health and Mental Hygiene
7. Florida Departments of Agriculture and Education Join Florida Dairy Farmers and NFL to Improve Health and Wellness in Florida Schools
8. Jefferson physician named 2010 Emergency Department Director of the Year
9. Dying cancer patient visits to emergency departments can be avoided
10. Netball Australia Joins Forces with DealsDirect.com.au, Australia's Leading Online Department Store
11. Justice Department Files for Immediate Relief Regarding Conditions at Conway Human Development Center, in Conway, Arkansas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & Associates, a family ... in North-Central West Virginia, is embarking on a cooperative charity effort with the ... , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young ...
(Date:8/18/2017)... ... 2017 , ... The Brian Gifford Agency, an Indiana-based firm providing asset protection ... Campagna Academy in a charity drive to provide for at-risk children and teens in ... Academy is a nonprofit organization that has offered critical programs to at-risk and foster ...
(Date:8/18/2017)... Missouri (PRWEB) , ... August 18, 2017 , ... “Emotions ... Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help change ... help children learn social and emotional skills, she created the Time-In Toolkit, which launched ...
(Date:8/18/2017)... ... , ... Alcovit, a lime-flavored beverage that rids the body of toxins linked ... now available through Jet.com. , After 25 years of development, the company released ... to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with ...
(Date:8/18/2017)... ... ... Mountains to Climb: A Journey of Love and Faith Through Trials”: a gripping ... shared to overcome struggles in life. “Our Mountains to Climb: A Journey of Love ... retired teacher and happily married since 1999; the author’s personal experiences drive this narrative. ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.24 ... 2017 to stockholders of record as of the close of ... subject to approval of the Board of Directors and may ...
(Date:8/4/2017)... CINCINNATI , Aug. 3, 2017  Agragen, ... science company active in the biopharmaceutical, nutraceutical, and ... its development of its lead drug candidates, AGR131.  ... a proinflammatory cytokine from the blood of patients ... psoriasis, and inflammatory bowel disease. ...
(Date:8/2/2017)... CaryRx, a next-generation full-service pharmacy, has announced the launch of ... Washington D.C. metropolitan area. CaryRx aims ... medications through the convenience of its patient-friendly mobile app. Prescriptions ... hour to any location in D.C. ... to Washington D.C. ," says Areo Nazari ...
Breaking Medicine Technology: